Aluro
METABOLIC

Semaglutide

GLP-1 receptor agonist

The first of the GLP-1s, and still the most studied. It curbs appetite and steadies blood sugar through a single pathway, which makes it a calm, well-understood place to begin.

What people notice

Appetite eases over the first couple of weeks, and cravings lose their pull. As the most studied option in its class, it's a reassuring first step for a lot of people.

Ben's take

A steady, predictable place to start, especially if Tirzepatide feels like a lot at first. It costs less, too.

Research summary

A GLP-1 receptor agonist that helps regulate appetite, slows gastric emptying, and steadies blood sugar. Widely studied for weight loss and for heart and metabolic health.

Details

Category
METABOLIC
Route
Weekly subcutaneous injection
Typical supply
≈1 month

Certificate of Analysis

Lab tested for identity and purity. Message me and I'll send the Certificate of Analysis.

Also in metabolic

Aluro carries research compounds. This is not medical advice. All information is based on published research and personal experience.

© MMXXVI · Aluro · Research Use Only37°48'21"N122°26'10"WSan Francisco, CA